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Introduction
Ca 2+ signals in cells are generated through the function of Ca 2+ channels that either release stored Ca 2+ from the endoplasmic reticulum (ER) or allow external Ca 2+ to enter across the plasma membrane (PM). The ER membrane-spanning STIM proteins are sensors of Ca 2+ stored in the ER and in response to Ca 2+ store-depletion trigger the opening of Orai Ca 2+ entry channels [1] . Decreased ER luminal Ca 2+ triggers STIM1 activation and translocation into ER-PM junctions where it binds to and opens the highly Ca 2+ -selective Orai family of "store-operated" PM channels [1, 2] . The store-operated Ca 2+ entry (SOCE) mediated by Orai channels is important for sustaining Ca 2+ oscillations, maintaining Ca 2+ homeostasis, and generating longer-term Ca 2+ signals that regulate gene expression and cell growth [1, 3] . Changes in the operation of STIM-mediated Orai channel function have important consequences in autoimmunity, inflammation, vascular diseases and cancer [4] [5] [6] .
The function and control of STIM and Orai proteins has been intensely studied [1, 2, 4, 7] . The luminal N-terminal domain of STIM1 contains EF-hands which sense depletion of Ca 2+ within the ER [8, 9] . Structural changes in the STIM1 N-terminus triggered by Ca 2+ dissociation, induce self-association between STIM1 proteins and an important conformational change in the cytoplasmic C-terminus of STIM1 which undergoes unfolding and exposure of the cytoplasmic Orai-interacting site [1, 2, 4] . A short 100-amino acid segment known as the STIM-Orai activating region (SOAR) [10] or CRAC activation domain (CAD) [11] was revealed within the cytoplasmic domain of STIM1 to be the minimal sequence able to both interact with and activate Orai channels. Structural analysis shows SOAR comprises four well-organized helices and exists as a dimer [12] . Biochemical evidence suggests the STIM1 molecule itself is a dimer in its resting and active state [12] [13] [14] [15] . The Orai channel protein has four transmembrane helices and crystallography reveals the channel to be a hexamer [16] . The N-terminal helices of each of the six Orai subunits form the central Orai channel pore [17] [18] [19] [20] . The Orai1 cytoplasmic N-and C-termini extend into the cytosol in close proximity to each other [16, 21] . It appears that these N-and C-terminal helices of Orai1 combine to interact with STIM1 [11, 22] , and both are required for STIM1-induced activation of the Orai channel [22] [23] [24] [25] [26] [27] [28] .
Although structural and biochemical approaches provide a significant understanding of the molecular interactions between STIM and Orai proteins, pharmacological approaches have not been forthcoming. Thus, there have been few specific chemical modifiers that are useful as probes to examine the STIM-Orai coupling and activation process. One molecule that has been useful is 2-aminoethoxydiphenyl borinate (2-APB). 2-APB has a complex, biphasic effect on STIM1-induced Orai1 channel A c c e p t e d M a n u s c r i p t 5 activation, lower levels (1-10 μM) enhancing and higher levels (10-100 μM) strongly inhibiting SOCE mediated by Orai [29, 30] . With sensitivity in the micromolar range, it would not be expected that the actions of 2-APB would be highly specific for Orai channels. Indeed, although widely used as an inhibitor of SOCE, 2-APB has similar inhibitory actions on InsP 3 receptor Ca 2+ release channels [31] [32] [33] , a range of TRP channels [34] [35] [36] [37] [38] [39] , and even Ca 2+ pumps [40, 41] . Despite these other effects, the actions of 2-APB on STIM/Orai-mediated SOCE have some curious and interesting facets. The Orai3 channel is shown to be directly activated by 2-APB without any requirement for STIM proteins [42] [43] [44] [45] [46] . 2-APB also has profound actions in promoting the functional coupling between STIM1 with Orai1 [46, 47] . Thus, using certain derivatives or mutants of STIM1 that are unable to bind to Orai1, 2-APB overcomes these defects and induces strong STIM1 binding and Orai1 channel activation [46, 47] .
Based on an earlier screen of compounds related to 2-APB [48] , two dimeric 2-APB derivatives, DPB162-AE and DPB163-AE (herein referred to as DPB162 and DPB163), were identified with more potent actions on STIM-induced Orai channel activation [33] . Here, we reveal that these compounds have not only high potency but also considerable specificity of action on STIM1/Orai1-dependent SOCE.
We narrowed their site of action to modification of the functional coupling between the SOAR fragment of STIM1 and the Orai1 channel. While they have no effect on SOAR-Orai1 interaction, they potently block SOAR-mediated Orai1 channel activation. However, their action is not consistent with modifying the Orai1 channel pore. Using a recently defined point mutation in SOAR (F394H) which completely prevents STIM1-Orai1 coupling [47] , we reveal DPB162 can restore binding and permit sustained functional coupling to activate Orai1. With the same SOAR mutant, 2-APB induces a similar but more rapid functional coupling to Orai1, but Orai1 activation is transient. We infer that the actions of both 2-APB and DPB162 are directed toward the STIM1-Orai1 coupling interface. Compared to 2-APB, DPB162 is a much more potent and specific STIM1/Orai1 functional uncoupler. But the action of both molecules appears highly dependent on the configuration of the STIM-Orai interface. The mixed activation and inhibition profiles of both molecules likely reflect a fine line between enhancing as opposed to preventing successful coupling of STIM1 to the Orai1 channel.
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Methods

Materials and DNA constructs
DPB162 and DPB163 were generously provided by Dr. Katsuhiko Mikoshiba (RIKEN, Japan).
EGTA, DMSO, nimodipine and 1-Oleoyl-2-acetyl-sn-glycerol (OAG) were purchased from SigmaAldrich. Thapsigargin (TG) was from EMD Biosciences (San Diego, CA). 2-APB was from Tocris
Bioscience. Fura-2/AM was from Molecular Probes. cDNA for CFP-tagged Orai3 was from James Putney Jr. (NIEHS, Triangle Park, NC), the GFP-α1C plasmid was from Dr. Kurt Beam (Univ. Colorado, Denver CO); TRPC3 cDNA was from Dr. Craig Montell (Johns Hopkins Univ.), TRPC6 cDNA was from BD Biosciences (Mountain View, CA) and subcloned into psDNA3 (Stratagene, La Jolla, CA).
STIMct C-terminally YFP-labeled constructs were inserted within the pIRESneo3 plasmid (Clontech, Palo Alto, CA) as described [46, 47] . STIM1ct-4EA-YFP was mutated from STIM1ct-YFP construct, and -F394H-SOAR-F394H, SOAR-F394H were made by Mutagenex, NJ.
Cell culture and transfection
HEK293 stably-transfected cells were derived and maintained in Dulbecco's modified Eagle's medium (Mediatech Inc, Manassas, VA) supplemented with 10% fetal bovine serum, penicillin and streptomycin (Gemini Bioproducts, CA) at 37 °C with 5% CO2 in G418 (100 μg/ml) as previously described [49, 50] . DT40 cells were maintained in RPMI 1640 (Mediatech Inc, Manassas, VA) as described [30] . Rat basophilic leukemia cell line RBL-2H3 were grown in the same medium but with heat-inactivated serum [51, 52] . Jurkat and CEM.3-71 cells were from ATCC (Rockville, MD). All plasmid transfections were undertaken by electroporation using the Bio-Rad Gene Pulser Xcell system in OPTI-MEM medium as previously described [47] . DNA constructs were introduced by electroporation at (25mm) in OPTI-MEM with 5% FBS and measurements undertaken 14-24 hours after transfection as A c c e p t e d M a n u s c r i p t 7 previously described [47, 53] . HEK293 cells stably expressing Orai1-CFP (HEK-Orai cells) or Orai3-CFP were generated by electroporation of pIRES constructs and selection as described [49] . Transient transfection levels of STIM1, STIM1-F394H, STIM1ct, and SOAR constructs were quantified previously [46, 47, 54] . We noted that transient transfection of the YFP-SOAR-F394H mutant resulted in expression in HEK-Orai1 cells that was lower than expression of the wildtype YFP-SOAR (Fig. S1A) . However, the proportion of cells that were expressing the YFP-SOAR-F394H mutant (93 out of 655 cells; 14%) was substantially below that of YFP-SOAR-expressing cells (220 out of 393; 56%). Indeed, the YFPintensity per cell for these two populations were not so different as shown in Fig. S1B 
Cytosolic Ca 2+ measurements
Intracellular Ca 2+ levels were measured by ratiometric imaging using fura-2. Loading of fura-2 and imaging of fura-2 fluorescence as described previously [56] imaging experiments were performed at room temperature and representative traces of at least three independent repeats are shown as mean ± SEM.
Automated multi-well Ca 2+ measurements
DT40 cells were cultured as previously described [46] . Prior to plating, cells were loaded in 15 ml tubes with fluo-4 while in suspension, as described for fura-2. Following fluo-4 loading, cells were counted in a Bio-Rad Automated Cell Counter and re-suspended in 3 mM Ca 2+ imaging buffer, to provide a final cell density of 55,000 cells per well in the 384 well plate. 20 μl of re-suspended cells were plated in each well in 384-well poly-l-lysine coated plates. Plates was centrifuged (3,000 rpm, 5 min) to settle 
Förster resonance energy transfer (FRET) measurements
These measurements were as described previously [47] . Average FRET measurements shown are typical of at least three independent analyses ± SEM.
Statistical analyses
Analysis of statistical significance was performed using unpaired Student's t test with GraphPad Prism 5 software. Results are expressed as means ± SEM, *** p<0.001.
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Results
DPB compounds have high potency and specificity for STIM/Orai-mediated SOCE
Although a great number of studies have described the effects of 2-APB on SOCE mediated by the combined actions of STIM and Orai proteins [1, 57] , only one report has appeared on the more potent dimeric 2-APB analogues, DPB162 and DPB163 (Fig. 1) Fig. 2C-E) . In each case, thapsigargin-mediated SOCE was almost completely inhibited by either compound at 2 μM added at time zero. These actions of DPB162 and DPB163 are in agreement with the results published previously [33] on these compounds for inhibition of both SOCE and the CRAC current mediated by STIM1-induced Orai1 channel activation. Thus, the DPB compounds have approximately 100-fold greater potency than 2-APB which has an IC 50 of greater than 20 μM [30] . We also assessed reversibility of the actions of DPB162 or 2-APB by applying washout (Fig. S3 ). The DPB162 effect was still almost complete after 10 min washout whereas the action of 2-APB was largely eliminated. The prolonged action of DPB162 compared with 2-APB may reflect a slower off-rate and would be consistent with its higher potency in blocking STIM/Orai-mediated SOCE.
Importantly, we determined that the DPB compounds, in contrast to 2-APB, have high specificity for store-operated channels among Ca 2+ permeable channels. We used HEK293 cells expressing the α 1C -subunit of the L-type Ca 2+ channel which gives robust nimodipine-sensitive Sr 2+ entry in response to depolarization induced by high K + [53] . At their maximal SOCE inhibitory level (2 μM), neither of the DPB compounds induced any decrease in L-type channel activity. In contrast, using 2-APB at the lowest A c c e p t e d M a n u s c r i p t concentration that maximally blocks SOCE (50 μM), there was almost complete block of L-type channelmediated Ca 2+ entry (Fig. 3A) . We also examined the actions of the DPB compounds on TRPC channel function. These channels have been reported to be store-sensitive, however, the role of the store-sensing STIM proteins in their activation remains controversial [1] . The TRPC3 and TRPC6 channels are characteristically activated by diacylglycerol through a mechanism that is independent of protein kinase C [58] . As shown in Fig. 3B and 3C, the DPB compounds at their maximal SOCE-inhibitory level (2 μM)
were without effect on either TRPC3 or TRPC6 channels stably expressed in HEK293 cells and activated by the cell-permeant diacylglycerol analogue, OAG. In contrast, we showed earlier that 2-APB completely blocks the function of TRPC3 and TRPC6 channels when applied at the level that blocks SOCE [32, 34, 59] . This represents an important distinction in specificity between the actions of DPBs and 2-APB. We examined the actions of DPB compounds on Ca 2+ pumping activity in cells. Earlier reports had suggested that 2-APB could have inhibitory actions on Ca 2+ pumping in cells [40, 41] . Our results reveal that DPBs did not alter the capacity of Ca 2+ stores whether added shortly before thapsigargin ( Fig. 2A ) or pre-incubated for 10 minutes (see subsequent figures). Thus, DPBs did not appear to alter SERCA-mediated Ca 2+ pumping into stores. We also examined whether the rate of Ca 
Assessment of DPB specificity for STIM and Orai subtypes using STIM or Orai knockout cells.
In the single earlier report on DPB compounds [33] , it was noted that they showed considerable specificity among Orai and STIM subtypes. We undertook studies to more definitively investigate such specificity by taking advantage of knockout DT40 chicken B cell lines exclusively expressing specific
Orai and STIM protein subtypes. The chicken genome is missing the Orai3 gene and chicken cells express only the Orai1 and Orai2 subtypes. Using the Orai2-knockout DT40 cell line, SOCE mediated exclusively by the Orai1 channel was completely blocked by either DPB162 or DPB163 at 2 μM ( Fig.   4A ). Using Orai1-knockout DT40 cells, SOCE mediated by Orai2 was considerably less sensitive to addition of DPB compounds. Even 13 min with DPB162 at 300 nM had no effect on Orai-2 mediated SOCE, and 3 μM DPB162 had barely a half-maximal effect (Fig. 4B ). Similar insensitivity was seen with DPB163. Limited solubility of the DPB compounds prevented addition at higher levels. Thus, Orai2
appears to have some 10-fold lower sensitivity to the DPB compounds. We initially investigated the actions of DPBs on Orai3 using stable Orai3-expressing HEK293 cells (HEK-Orai3) transfected with channel is well known to be activated by 2-APB without any requirement for STIM proteins [42] [43] [44] [45] [46] .
Using HEK-Orai3 cells in which stores had not been depleted of Ca 2+ , while DPB162 had no effect, the addition of 2-APB resulted in a robust activation of Orai3-mediated SOCE which was unaltered by either DPB162 or DPB163 (Fig. 4D ). To investigate Orai-3 more directly, we expressed Orai3 in the DT40
Orai1/Orai2 double knockout cell line [46] (Fig. 4E ). Orai3-expressing DKO cells had robust SOCE compared to a complete lack of SOCE in untransfected cells (Fig. 4E , right) or in Orai3-expressing DKO cells without store-emptying (Fig. 4E, left) . The Orai3-mediated SOCE was unaffected by DPB162 or DPB163, providing compelling evidence that Orai3, even in a store-dependent mode, is distinct from Orai1. Intriguingly, despite their potent inhibitory action on SOCE, the powerful direct effect of 2-APB observed by several groups to induce STIM-independent activation of Orai3 channels, was not seen for the DPB compounds.
We extended our specificity studies to compare the actions of DPBs on the function of the two STIM proteins, STIM1 and STIM2. This was important since several significant distinctions in the function and Orai-coupling of STIM1 and STIM2 have been reported [47, 60] . We turned again to the DT40 cell lines in which STIM1 and/or STIM2 genes have been knocked out. Using the STIM2 knockout DT40 line, we observed almost full inhibition of SOCE ( Fig. 5A ) consistent with a STIM1-mediated Ca 2+ entry profile. In contrast, the smaller SOCE observed in the STIM1 knockout line was not inhibited by either DPB162 or DPB163 (Fig. 5B ). Intriguingly, both compounds showed some activation of STIM2-mediated Ca 2+ entry. A slight increase at 300 nM was seen with DPB162, and a substantial increase between 100 and 300 nM was seen with DPB163 ( Fig. 5C ). In the earlier report [33] , it was suggested that some of the increased CRAC current observed, especially with DPB163, might have been due to STIM2, but this was from observations on heterologously expressed systems. The results here with knockout cell lines provide definitive information on the stark difference in effects of the DPB compounds on STIM1 and STIM2. We recently revealed important differences between the functional coupling of STIM1 and STIM2 with Orai1 channels [47] . Thus, we hypothesize that the action of DPB compounds is directed toward the site of interaction between STIM and Orai proteins.
DPB162 blockade of Orai1 activation has no requirement for the STIM1 N-terminal domain
The site of action of DPB compounds was an important question to address. In their earlier study, Goto et al [33] suggested that the DPBs might exert their effects by modifying the store depletionmediated clustering of STIM1 proteins. The initial sensing of Ca 2+ depletion and triggering of STIM1
clustering is mediated by the ER luminal N-terminus of STIM1 which contains the Ca 2+ -sensing EF-hand (Fig. 6C) . These results are important, providing strong evidence that the action of DPB162 on STIM1-induced Orai1 activation does not require the presence of the STIM1 N-terminal domain, nor the emptying of Ca 2+ stores.
Functional not physical coupling of dimeric SOAR with Orai1 is blocked by DPB162 and 2-APB
To further pinpoint the actions of DPB162, we examined its effects on the operation of SOAR, the minimal fragment of STIM1 able to functionally couple to Orai1 [10, 11] . In these studies we also compared the actions of DPB162 and 2-APB. SOAR-YFP expressed in HEK-Orai1 cells gave constitutive Ca 2+ entry rapidly blocked by 50 µM 2-APB (Fig. 7A) . Treatment of cells with 2 μM DPB162 was also inhibitory, almost completely blocking SOAR-induced constitutive Ca 2+ entry (Fig.   7B ). Intrinsic FRET between YFP-SOAR and Orai-CFP is high as we recently described [47] since SOAR is avidly bound to Orai1 at the plasma membrane. DPB162 did not induce any change in FRET level and 2-APB increased it slightly (Fig. 7C ). As seen in Fig. 7D , expressed YFP-SOAR appears almost exclusively in the plasma membrane and is mostly absent from the cytosol (Fig. 8D, top row) .
The overlap of YFP-SOAR with Orai1-CFP at the plasma membrane was almost complete as revealed in the merged image. Neither DPB162 addition (Fig. 7D , middle row) nor subsequent 2-APB addition ( Importantly, these FRET and imaging results reveal that DPB and 2-APB do not inhibit SOCE by dissociating the SOAR-Orai1 interaction. We also examined the action of 2 μM DPB162 on the strong FRET signal between holo-STIM1-YFP and Orai-CFP following store-depletion, and observed no change (Fig. S4) . Thus, DPB162 at the concentration that maximally blocks SOCE does not alter the store depletion-mediated interaction between full-length STIM1 and Orai1 in ER-PM junctions.
Previous studies show that STIM1 likely exists in a dimeric state, both at rest and in its activation of Orai1 channels [12, 21] . One possibility was the 2-APB or DPB162 might function to inhibit SOAR by preventing or altering the formation of SOAR dimers. Hence we examined the function of a concatemeric construct expressing a YFP-tagged tandem repeat of two SOAR fragments with an intervening 21-amino acid spacer sequence (YFP-SOAR-SOAR), similar to a construct published earlier [61] . Compared with SOAR, we observed that the YFP-SOAR-SOAR protein was more uniformly expressed in HEK-Orai1 cells, giving robust and consistent Ca 2+ responses ( Fig. 7E-G) . The dimeric construct mediated SOCE that was rapidly and completely blocked by either 2-APB or DPB162. FRET changes induced by DPB162 were minimal and 2-APB induced a slight FRET increase (Fig. 7H ).
Neither DPB162 nor 2-APB altered the strong co-association of YFP-SOAR-SOAR with Orai1 at the plasma membrane (Fig. 7I) . Again, the data reveal that the block of Ca 2+ entry by 2-APB or DPB162 is not due to any SOAR-Orai1 dissociation. Since the concatemeric YFP-SOAR-SOAR protein would favor dimer formation, these data provide good evidence that the actions of either DPB162 or 2-APB are unlikely to be mediated by dimer dissociation. However, we further extended the study to examine the effect of DPB162 directly on dimeric association between SOAR subunits. Thus, measuring FRET between co-expressed YFP-SOAR and CFP-SOAR, we observed no alteration by DPB162 (Fig. S5) .
Unlike 2-APB, DPB162 does not promote physical and functional coupling of inactive STIM1ct
A considerable number of studies have documented the unusual biphasic kinetics of the action of 2-APB on STIM/Orai mediated Ca 2+ signaling [1, 29, 30, 62] . At low μM levels, 2-APB can enhance SOCE, whereas at 50 μM it is strongly inhibitory. The DPB162 molecule, although a simple dimer of 2-APB, shows much higher potency and simpler kinetics on STIM1/Orai1-mediated SOCE (Fig. 2B) . A related and remarkable characteristic of the action of 2-APB is its ability to trigger activation of the otherwise inactive STIM1ct molecule. Thus, 2-APB at the concentration (50 μM) which normally completely inhibits SOCE, induces instead a profound activation of the physical interaction between STIM1ct and Orai1 [46, 47] . This 2-APB induced interaction triggers both Ca 2+ entry and authentic CRAC current mediated by the Orai1 channel, these actions all entirely independent of any storedepletion [46, 47] . As shown above (Fig. 6A) , HEK-Orai1 cells transiently expressing STIM1ct-YFP, Fig. 8A , the addition of DPB162 at its maximal SOCEinhibitory level (2 μM) had no effect. In contrast, the maximal SOCE-inhibitory level of 2-APB (50 μM)
induced an acute and profound activation of Ca 2+ entry. Even with 10-min preincubation, DPB162 did not change Ca 2+ entry (Fig. 8B) . Unexpectedly, added either acutely or with preincubation, DPB162 did not block the activating effect of 2-APB on Orai1 function. Examination of FRET between STIM1ct-YFP and Orai1-CFP revealed no DPB162-induced interaction between these proteins in contrast to the rapid, substantial increase in FRET induced by 2-APB (Fig. 8C ).
DPB162 induces dichotomous physical and functional coupling of the Orai1-coupling-defective
STIM1-F394H mutant
We extended investigation of this remarkable difference of effect of 2-APB and DPB162 using a mutated form of whole STIM1. We recently identified a residue in the STIM-Orai-activating region (SOAR) of the C-terminal STIM1 domain (Phe-394) that is crucial to both the binding to and activation of Orai1 channels [47] . The single F394H mutation prevents store-induced STIM1-Orai1 FRET and any store-induced activation of Orai1 channels [47] . Importantly, using HEK-Orai1 cells expressing the F394H mutation of STIM1-YFP, addition of 50 μM 2-APB completely overcomes the mutational defect, restoring high STIM-Orai FRET and rapid activation of Orai1 channel function (Fig. 8D-F ). This restoring action of 2-APB was reminiscent of its effect described above on STIM1ct, except with STIM1-F394, the effect of 2-APB has an absolute requirement for store-depletion [47] . Unlike 2-APB, acute addition of DPB162 had no activating effect on STIM1-F394H (Fig. 8D) . Also, DPB162 did not block the effect of 2-APB (Fig. 8D) . After a 10 min pre-incubation, a very slight activating effect on SOCE was detected with DPB162 but again no decrease in the 2-APB-induced SOCE activation (Fig. 8E) .
Examining FRET between Orai1-CFP and STIM1-F394H-YFP, we observed a rapid increase in signal upon addition of DPB162 (Fig. 8F) . The FRET signal was further enhanced upon addition of 2-APB. as shown in Fig. 9D . Thus, the single point mutation in the SOAR-F394H mutant is sufficient to give a weak interaction with Orai1 that is rapidly and substantially increased with DPB162 or 2-APB.
We also utilized the dimeric YFP-SOAR-SOAR construct with the F394H mutation in each SOAR unit (YFP-SOAR-FH-SOAR-FH). As mentioned above, this mutated SOAR construct was more stably expressed than SOAR-FH (see Fig. S1 ). With this construct, 2-APB again induced rapid and transient Ca 2+ entry (Fig. 9E) . Now the effect of DPB162 was faster and larger ( Fig. 9F ) than with the monomeric SOAR mutant, and was also sustained with time. DPB162 induced a rapid onset of FRET between YFP-SOAR-FH-SOAR-FH and Orai1-CFP (Fig. 9G) although, as for the SOAR monomer, not quite as substantial as that induced by 2-APB. Note, the resting FRET value for the wildtype YFP-
SOAR-FH-SOAR-FH / Oria1 interaction was almost 50% higher than the YFP-SOAR-F394H / Orai1
FRET value (Fig. 9D) suggesting it has somewhat enhanced association. Imaging revealed that the YFP-SOAR-FH-SOAR-FH was mostly cytosolic at rest (Fig. 9H top row) , and that DPB162 induced substantial movement to the plasma membrane and almost complete overlap with Orai1-CFP ( appears the SOAR dimer has the most conducive structure for restoration by DP162.
Discussion
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A c c e p t e d M a n u s c r i p t The specificity of action of DPBs among STIM and Orai subtypes is a further significant finding.
This was addressed in the earlier overexpression studies of Goto et al [33] , however the results here utilized DT40 knockout cell lines in which specific STIM and Orai subtypes had been eliminated. The results reveal that DPB162 and DPB163 target Orai1 and Orai2 channels, although their effect on the latter require higher concentrations. Even at high levels, neither DPB162 nor DPB163 blocked Orai3 channels. Among the two STIM subtypes, the potent action of DPBs was remarkably selective for STIM1. Whereas DPB162 had little effect on STIM2, the DPB163 analogue induced a profound activation of STIM2-mediated SOCE over the narrow 100-300 nM range. This suggests that the DPB compounds would be useful tools to selectively probe the actions of STIM2 in store-operated Ca 2+ signaling responses. However, in most cell systems both STIM1 and STIM2 are expressed and it would be unclear what effect DPBs would exert on heterologously expressed STIM1 and STIM2 which would include mixed STIM1/STIM2 aggregates [67] In the earlier study [33] , it was suggested that in cells expressing STIM1, the action of 2-APB might be to prevent STIM1aggregation. However, we reveal here that the inhibitory action of DPB162 is observed on the cytosolic STIM1ct and SOAR fragments which do not undergo store-dependent aggregation. Moreover, in cells expressing both STIM1 and Orai1, we did not observe any alteration in the ability of STIM1 or Orai1 to move into puncta in response to store-depletion. Hence, the store-
Page 18 of 39
A c c e p t e d M a n u s c r i p t induced aggregation and translocation of STIM1 proteins into Orai1-assocaited ER-PM junctions was not affected.
While DPBs are clearly far more potent and specific blockers of STIM1/Orai1-mediated SOCE than 2-APB, they markedly differ in their effects from the complex actions of 2-APB. The 2-APB molecule, although much weaker in blocking Ca 2+ entry, is able to "force" the poorly active STIM1ct fragment to bind and activate the Orai1 channel, albeit transiently. Likewise, the full-length STIM1-F394H molecule, mutated at a crucial residue making it defective in both Orai1 binding and gating, is induced by 2-APB to bind to and gate the Orai1 channel. In both cases, 2-APB activates authentic CRAC current [46, 47] hence 2-APB causes inactive STIM1 to induce the correct conformational change in Orai1 that gates its channel activity. DPB162 neither mimics this action of 2-APB on Orai1, nor, curiously, does it block the 2-APB-induced Orai1 gating. This is important indicating that 2-APB has locked-in a STIM1-Orai1 coupling configuration that now excludes the action of DPB162 which is normally a powerful blocker of Orai1 channel activation. We may also conclude that DBP-162 does not function as a simple Orai1 poreblocking agent.
The blocking action of DPB162 on the activated holo-STIM1 protein appears to be the same as with the SOAR fragment. Studies reveal that the holo-STIM1 molecule unfolds during the store-induced activation process to expose the SOAR moiety [1, 68] . The isolated STIM1ct molecule has not undergone the activation process and is largely inactive [46] . However, the constitutively active STIM1ct-4EA mutant appears to be in the unfolded mode [12, 26] and, like activated holo-STIM1 or SOAR, allows access of DPB162 which prevents Orai1 activation. The observation that DPB162 blocks the action of STIM1ct-4EA suggests that this mutation behaves more like the store depletion-activated holo-STIM1 protein. But this effect of DPB162 is quite distinct from the 2-APB-forced activation of STIM1ct or STIM1-F394H which excludes any blocking action of DPB162.
The coupling interaction between STIM1 and Orai1 is between the short active SOAR segment of STIM1 and a combination of the N-and C-termini of Orai1 [10, 11, 16, 28] . The C-terminal sequence of Orai1 is considered to provide a strong binding site for SOAR and the N-terminus to mediate gating of the channel itself as a consequence of SOAR binding [11, 28] . Recently, the discrete operation of these two Orai1 sites has been reconsidered and instead, the close proximity of the N-and C-termini may create 
